Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 7, 2014, Pages 1358-1371

  Huang, Tze Sing ^a   Chen, Yi Jen ^b,c   Chou, Teh Ying ^b,c   Chen, Chih Yao ^b   Li, Hsin Yang ^b,c   Huang, Ben Shian ^c   Tsai, Hsiao Wen ^b,c   Lan, Hsin Yi ^c   Chang, Cheng Hsuan ^b   Twu, Nae Fang ^b   Yen, Ming Shyen ^b   Wang, Peng Hui ^b,c   Chao, Kuan Chong ^b   Lee, Chun Chung ^a   Yang, Muh Hwa ^b,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adenomyosis; Angiogenesis; Epithelial mesenchymal transition; Oestrogen; Slug

Indexed keywords

ESTROGEN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADENOMYOSIS; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME IMMUNOASSAY; EPITHELIUM CELL; FEMALE; HUMAN; METABOLISM; MOUSE; MYOMETRIUM; NEOVASCULARIZATION (PATHOLOGY); NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; WESTERN BLOTTING;

ADENOMYOSIS; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; ENDOMETRIOSIS; ENDOMETRIUM; EPITHELIAL CELLS; ESTROGENS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED NOD; MICE, SCID; MYOMETRIUM; NEOVASCULARIZATION, PATHOLOGIC; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84905036860     PISSN: 15821838     EISSN: 15824934     Source Type: Journal    
DOI: 10.1111/jcmm.12300     Document Type: Article

References (64)

1. Arnold LL, Ascher SM, Schruefer JJ, et al. The nonsurgical diagnosis of adenomyosis. Obstet Gynecol. 1995; 86: 461-5.
2. Juang CM, Chou P, Yen MS, et al. Adenomyosis and risk of preterm delivery. BJOG. 2007; 114: 165-9.
3. Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update. 2014; 20: 386-402.
4. Benagiano G, Brosens I. The endometrium in adenomyosis. Womens Health. 2012; 8: 301-12.
5. Chen YJ, Li HY, Huang CH, et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. J Pathol. 2010; 222: 261-70.
6. Taylor RN, Yu J, Torres PB, et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci. 2009; 16: 140-6.
7. Kang S, Zhao J, Liu Q, et al. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Environ Mol Mutagen. 2009; 50: 361-6.
8. Goteri G, Lucarini G, Montik N, et al. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1alpha (HIF-1alpha), and microvessel density in endometrial tissue in women with adenomyosis. Int J Gynecol Pathol. 2009; 28: 157-63.
9. Albrecht ED, Babischkin JS, Lidor Y, et al. Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod. 2003; 18: 2039-47.
10. Niklaus AL, Aberdeen GW, Babischkin JS, et al. Effect of estrogen on vascular endothelial growth/permeability factor expression by glandular epithelial and stromal cells in the baboon endometrium. Biol Reprod. 2003; 68: 1997-2004.
11. Nayak NR, Brenner RM. Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J Clin Endocrinol Metab. 2002; 87: 1845-55.
12. Mueller MD, Vigne JL, Minchenko A, et al. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci USA. 2000; 97: 10972-7.
13. Moller B, Rasmussen C, Lindblom B, et al. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod. 2001; 7: 65-72.
14. Charnock-Jones DS, Sharkey AM, Rajput-Williams J, et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod. 1993; 48: 1120-8.
15. Critchley HO, Brenner RM, Henderson TA, et al. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab. 2001; 86: 1370-8.
16. Ferrara N, Houck K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992; 13: 18-32.
17. Thiery JP, Acloque H, Huang RYJ, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139: 871-90.
18. Rodrigues CO, Nerlick ST, White EL, et al. A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development. Development. 2008; 135: 1903-11.
19. Mironchik Y, Winnard PT Jr, Vesuna F, et al. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res. 2005; 65: 10801-9.
20. Peinado H, Marin F, Cubillo E, et al. Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J Cell Sci. 2004; 117: 2827-39.
21. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119: 1420-8.
22. Chen YJ, Li HY, Chang YL, et al. Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors. Fertil Steril. 2010; 94: 1972-9, 9 e1-4.
23. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975; 122: 262-3.
24. Tan O, Ornek T, Fadiel A, et al. Expression and activation of the membrane-cytoskeleton protein ezrin during the normal endometrial cycle. Fertil Steril. 2012; 97: 192-9 e2.
25. Pairleitner H, Steiner H, Hasenoehrl G, et al. Three-dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization. Ultrasound Obstet Gynecol. 1999; 14: 139-43.
26. Wu MH, Tsai SJ, Pan HA, et al. Three-dimensional power Doppler imaging of ovarian stromal blood flow in women with endometriosis undergoing in vitro fertilization. Ultrasound Obstet Gynecol. 2003; 21: 480-5.
27. Huang CY, Wang HI, Wang PH, et al. Mean grey value is lower in endometriomas: differentiating a hypoechogenic adnexal cyst by 3-dimensional power Doppler ultrasound-a preliminary study. J Chin Med Assoc. 2011; 74: 75-80.
28. Abulafia O, Sherer DM. Angiogenesis of the endometrium. Obstet Gynecol. 1999; 94: 148-53.
29. Jarvela IY, Sladkevicius P, Kelly S, et al. Three-dimensional sonographic and power Doppler characterization of ovaries in late follicular phase. Ultrasound Obstet Gynecol. 2002; 20: 281-5.
30. Chen YC, Su YN, Chou PC, et al. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J Biol Chem. 2005; 280: 32505-11.
31. Yang MH, Chiang WC, Chou TY, et al. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res. 2006; 12: 507-15.
32. Remmele W, Schicketanz KH. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract. 1993; 189: 862-6.
33. Lee CC, Liu KJ, Wu YC, et al. Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells. Inflammation. 2011; 34: 209-21.
34. Chen JS, Hsu YM, Chen CC, et al. Secreted heat shock protein 90alpha induces colorectal cancer cell invasion through CD91/LRP-1 and NF-kappaB-mediated integrin alphaV expression. J Biol Chem. 2010; 285: 25458-66.
35. Chen WS, Chen CC, Chen LL, et al. Secreted heat shock protein 90alpha (HSP90alpha) induces nuclear factor-kappaB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion. J Biol Chem. 2013; 288: 9001-10.
36. Yang L, Xie S, Jamaluddin MS, et al. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. J Biol Chem. 2005; 280: 33558-65.
37. Pearson T, Greiner DL, Shultz LD. Humanized SCID mouse models for biomedical research. Curr Top Microbiol Immunol. 2008; 324: 25-51.
38. Grummer R, Schwarzer F, Bainczyk K, et al. Peritoneal endometriosis: validation of an in-vivo model. Hum Reprod. 2001; 16: 1736-43.
39. Fang C, Avis I, Salomon D, et al. Novel phenotypic fluorescent three-dimensional platforms for high-throughput drug screening and personalized chemotherapy. J Cancer. 2013; 4: 402-15.
40. Wang D, Liu Y, Han J, et al. Puerarin suppresses invasion and vascularization of endometriosis tissue stimulated by 17beta-estradiol. PLoS ONE. 2011; 6: e25011.
41. Cheng YH, Imir A, Fenkci V, et al. Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism. Am J Obstet Gynecol. 2007; 196: 391 e1-7.
42. Kim SH, Lee HW, Kim YH, et al. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis. Hum Reprod. 2009; 24: 1133-41.
43. Plante BJ, Lessey BA, Taylor RN, et al. G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium. Reprod Sci. 2012; 19: 684-93.
44. Kim YH, Kim SH, Lee HW, et al. Increased viability of endometrial cells by in vitro treatment with di-(2-ethylhexyl) phthalate. Fertil Steril. 2010; 94: 2413-6.
45. Guay S, Akoum A. Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology. Reproduction. 2007; 134: 525-34.
46. Hsu CY, Hsieh TH, Tsai CF, et al. miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. J Pathol. 2014; 232: 330-43.
47. Becker CM, Sampson DA, Short SM, et al. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. Fertil Steril. 2006; 85: 71-7.
48. Shen Z, Fahey JV, Bodwell JE, et al. Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts. PLoS ONE. 2013; 8: e69854.
49. Yoshie M, Miyajima E, Kyo S, et al. Stathmin, a microtubule regulatory protein, is associated with hypoxia-inducible factor-1alpha levels in human endometrial and endothelial cells. Endocrinology. 2009; 150: 2413-8.
50. Herve MA, Meduri G, Petit FG, et al. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus. J Endocrinol. 2006; 188: 91-9.
51. Fan YL, Zheng M, Tang YL, et al. A new perspective of vasculogenic mimicry: EMT and cancer stem cells. Oncol Lett. 2013; 6: 1174-80.
52. Gasperini P, Espigol-Frigole G, McCormick PJ, et al. Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer Res. 2012; 72: 1157-69.
53. Chang L, Wong F, Niessen K, et al. Notch activation promotes endothelial survival through a PI3K-Slug axis. Microvasc Res. 2013; 89: 80-5.
54. Garcia J, Sandi MJ, Cordelier P, et al. Tie1 deficiency induces endothelial-mesenchymal transition. EMBO Rep. 2012; 13: 431-9.
55. Yang J, McNeish B, Butterfield C, et al. Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. FASEB J. 2013; 27: 45-50.
56. Park JS, Choi SY, Lee JH, et al. Interleukin-32beta stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway. Cell Oncol. 2013; 36: 493-503.
57. Thiery JP. Epithelial-mesenchymal transitions in cancer onset and progression. Bulletin De L Academie Nationale De Medecine. 2009; 193: 1969-78.
58. Fraser HM, Wilson H, Silvestri A, et al. The role of vascular endothelial growth factor and estradiol in the regulation of endometrial angiogenesis and cell proliferation in the marmoset. Endocrinology. 2008; 149: 4413-20.
59. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998; 4: 323-36.
60. Filicori M, Butler JP, Crowley WF Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest. 1984; 73: 1638-47.
61. Girling JE, Rogers PA. Recent advances in endometrial angiogenesis research. Angiogenesis. 2005; 8: 89-99.
62. Vazquez F, Rodriguez-Manzaneque JC, Lydon JP, et al. Progesterone regulates proliferation of endothelial cells. J Biol Chem. 1999; 274: 2185-92.
63. Iruela-Arispe ML, Rodriguez-Manzaneque JC, Abu-Jawdeh G. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors. Microcirculation. 1999; 6: 127-40.
64. Monckedieck V, Sannecke C, Husen B, et al. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mol Hum Reprod. 2009; 15: 633-43.